Literature DB >> 33351159

[Laparostoma-Avoidance and treatment of complications].

Ulrich A Dietz1, Johannes Baur2, Rein Jan Piso3, Arnulf Willms4, Robert Schwab4, Armin Wiegering5.   

Abstract

The open abdomen (OA) is an established concept for treating severe abdominal diseases. The most frequent reasons for placement of an open abdomen are abdominal sepsis (e.g. from intestinal perforation or anastomotic leakage), severe abdominal organ injury and abdominal compartment syndrome. The pathophysiology is much more complex than the surgeon's eye can see in an OA. The temporary closure of the abdominal wall ensures sufficient drainage of infected ascites, protection of the intestinal loops and conditioning of the abdominal wall in order to be able carry out definitive closure of the abdominal wall at the end of the surgical treatment. Negative peritoneal pressure therapy combined with fascia traction (with or without mesh) is well-established in the management of an open abdomen.

Entities:  

Keywords:  Abdominal compartment syndrome; Enteroatmospheric fistula; Intra-abdominal hypertension; Negative peritoneal pressure therapy; Open abdomen

Mesh:

Year:  2021        PMID: 33351159     DOI: 10.1007/s00104-020-01322-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

1.  The Significance of Visceral Protection in Preventing Enteroatmospheric Fistulae During Open Abdomen Treatment in Patients With Secondary Peritonitis: A Propensity Score-matched Case-control Analysis.

Authors:  Arnulf G Willms; Sebastian Schaaf; Nicolay Zimmermann; Robert Schwab; Christoph Güsgen; Tim O Vilz; Jörg C Kalff; Martin W von Websky
Journal:  Ann Surg       Date:  2021-06-01       Impact factor: 12.969

2.  Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization.

Authors:  Bryan A Cotton; Oliver L Gunter; James Isbell; Brigham K Au; Amy M Robertson; John A Morris; Paul St Jacques; Pampee P Young
Journal:  J Trauma       Date:  2008-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.